欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/3079/001
药品名称	Olanzapin-ratiopharm 2,5 mg Tabletten
活性成分	olanzapine 2.5 mg
剂型	Tablet
上市许可持有人	ratiopharm GmbH Graf-Arco- Strasse 3 D-89079 Ulm Germany
参考成员国 - 产品名称	Germany (DE) Olanzapin-ratiopharm 2,5 mg Tabletten
互认成员国 - 产品名称	Finland (FI) Austria (AT)
许可日期	2008/04/05
最近更新日期	2023/05/18
药物ATC编码	N05AH03 olanzapine
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final Product Information \| common-final-labip-3079(001-006)-V036Date of last change:2020/09/18 Final Product Information \| common-final-labop-3079(001-006)-V036Date of last change:2020/09/18 Final Product Information \| common-final-labop-3079(007,009-010)-V036Date of last change:2020/09/18 Final Product Information \| common-final-labip-3079(007,009-010)-V036Date of last change:2020/09/18 Final Product Information \| common-final-pl-3079(007,009-010)-V036Date of last change:2020/09/18 Final Product Information \| common-final-pl-3079(001-006)-V036Date of last change:2020/09/18 Final Product Information \| common-final-spc-3079(001-006)-V036Date of last change:2020/09/18 Final Product Information \| common-final-spc-3079(007,009-010)-V036Date of last change:2020/09/18 PAR \| PAREN-DE 3079_OlanzapinDate of last change:2014/07/22
市场状态	Positive